Skip to content

APOTHEEK DE LAET: what changed

What changed

APOTHEEK DE LAET

BE 0405.063.684
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€16,999
2024 · -€8,338-€8,662
Equity
€559,191
2024 · €576,190-€16,999
Cash
€118,225
2024 · €451,897-€333,671
Balance sheet total
€583,400
2024 · €887,432-€304,031

Largest movements

2024 to 2025
Assets
  • Cash -€333,671

    down €333,671 (-73.8%), from €451,897 to €118,225

    mainly Other debts (-€276,690) and Stocks and contracts (-€54,060)

  • Stocks and contracts +€54,060

    up €54,060 (+16.1%), from €336,796 to €390,856

  • Receivables within one year -€22,096

    down €22,096 (-77.0%), from €28,708 to €6,612

    of which Other amounts receivable: -€25,090

Equity and liabilities
  • Other debts -€276,690

    down €276,690 (-97.4%), from €283,956 to €7,266

  • Reserves -€16,999

    down €16,999 (-3.3%), from €514,190 to €497,191

    of which Distributable reserves: -€16,999

  • Tax, wage and social debts -€8,883

    down €8,883 (-59.5%), from €14,926 to €6,043

Income statement
  • Gross operating margin -€17,563

    down €17,563, from €15,921 to -€1,642

  • Depreciation -€9,813

    down €9,813 (-81.2%), from €12,085 to €2,272

  • Financial income -€2,257

    down €2,257 (-39.0%), from €5,785 to €3,528

  • Financial charges -€1,362

    down €1,362 (-8.4%), from €16,224 to €14,862

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€8,338
Gross operating margin -€17,563
Depreciation +€9,813
Other operating charges -€4
Financial income -€2,257
Financial charges +€1,362
Taxes -€12
Result 2025 -€16,999
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€333,671
Investment €0
Financing €0
Cash 2024 €451,897
Net result for the year -€16,999
Depreciation +€2,272
Stocks and contracts -€54,060
Receivables within one year +€22,096
Smaller working-capital items -€281
Tax, wage and social debts -€8,883
Other debts -€276,690
Accrued charges and deferred income -€1,127
Cash 2025 €118,225
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €887,432 €583,400 -€304,031 -34.3%
Fixed assets 21/28 €68,395 €66,123 -€2,272 -3.3%
Tangible fixed assets 22/27 €68,145 €65,873 -€2,272 -3.3%
Land and buildings 22 €64,680 €63,360 -€1,320 -2.0%
Plant, machinery and equipment 23 €2,803 €2,377 -€426 -15.2%
Furniture and vehicles 24 €662 €136 -€526 -79.5%
Other tangible fixed assets 26 €0 - =
Financial fixed assets 28 €250 €250 = 0.0%
Current assets 29/58 €819,037 €517,278 -€301,759 -36.8%
Stocks and contracts in progress 3 €336,796 €390,856 +€54,060 +16.1%
Stocks 30/36 €336,796 €390,856 +€54,060 +16.1%
Amounts receivable within one year 40/41 €28,708 €6,612 -€22,096 -77.0%
Trade receivables 40 €272 €3,267 +€2,995 +1,100%
Other amounts receivable 41 €28,436 €3,345 -€25,090 -88.2%
Cash at bank and in hand 54/58 €451,897 €118,225 -€333,671 -73.8%
Deferred charges and accrued income 490/1 €1,636 €1,585 -€51 -3.1%
Total equity and liabilities 10/49 €887,432 €583,400 -€304,031 -34.3%
Equity 10/15 €576,190 €559,191 -€16,999 -3.0%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €514,190 €497,191 -€16,999 -3.3%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €507,990 €490,991 -€16,999 -3.3%
Amounts payable 17/49 €311,242 €24,210 -€287,032 -92.2%
Amounts payable within one year 42/48 €299,989 €14,084 -€285,905 -95.3%
Trade debts 44 €1,107 €775 -€332 -30.0%
Suppliers 440/4 €1,107 €775 -€332 -30.0%
Taxes, remuneration and social security 45 €14,926 €6,043 -€8,883 -59.5%
Taxes 450/3 €14,926 €6,043 -€8,883 -59.5%
Other amounts payable 47/48 €283,956 €7,266 -€276,690 -97.4%
Accrued charges and deferred income 492/3 €11,253 €10,126 -€1,127 -10.0%
Non-recurring operating income 76A €6,925 €0 -€6,925 -100%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €12,085 €2,272 -€9,813 -81.2%
Other operating charges 640/8 €1,533 €1,538 +€4 +0.3%
Gross operating margin 9900 €15,921 -€1,642 -€17,563
Operating profit (loss) 9901 €2,303 -€5,452 -€7,755
Financial income 75/76B €5,785 €3,528 -€2,257 -39.0%
Recurring financial income 75 €5,785 €3,528 -€2,257 -39.0%
Financial charges 65/66B €16,224 €14,862 -€1,362 -8.4%
Recurring financial charges 65 €16,224 €14,862 -€1,362 -8.4%
Profit (loss) for the period before taxes 9903 -€8,136 -€16,786 -€8,650 -106%
Income taxes 67/77 €202 €213 +€12 +5.7%
Profit (loss) for the period 9904 -€8,338 -€16,999 -€8,662 -104%
Profit (loss) for the period to be appropriated 9905 -€8,338 -€16,999 -€8,662 -104%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.